Downregulation of ITGA5 inhibits lymphangiogenesis and cell migration and invasion in male laryngeal squamous cell carcinoma
暂无分享,去创建一个
Jun Huang | Jingru Liu | Ruolan You | Diyu Hou | Xiaoting Wang | Huimin Huang | Fuwen Yang | Meihong Yao | Long Wu
[1] H. Deng,et al. ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma , 2022, Journal of clinical laboratory analysis.
[2] Meiwan Chen,et al. Sequential Release of Pooled siRNAs and Paclitaxel by Aptamer-Functionalized Shell-Core Nanoparticles to Overcome Paclitaxel Resistance of Prostate Cancer. , 2021, ACS applied materials & interfaces.
[3] K. Pantel,et al. Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions , 2021, Oncogene.
[4] Di Wu,et al. Dysregulated YY1/PRMT5 axis promotes the progression and metastasis of laryngeal cancer by targeting Hippo pathway , 2020, Journal of Cellular and Molecular Medicine.
[5] H. Ford,et al. VEGF-C Mediates Tumor Growth and Metastasis Through Promoting EMT- Epithelial Breast Cancer cell Crosstalk , 2020, Oncogene.
[6] Di Wu,et al. PRMT5/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma , 2020, Cell Death & Disease.
[7] Hui-Hua Li,et al. Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors , 2020, Frontiers in Physiology.
[8] Gang Wang,et al. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors , 2020, BMC cancer.
[9] T. Qiao,et al. Radiotherapy Versus Surgery–Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms , 2020, Frontiers in Oncology.
[10] K. Alitalo,et al. VEGF-C Protects the Integrity of Bone Marrow Perivascular Niche. , 2020, Blood.
[11] I. Talaat,et al. Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms , 2020, International journal of molecular sciences.
[12] M. Hsu,et al. WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade , 2019, Front. Oncol..
[13] H. Qin,et al. Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker , 2019, Molecular oncology.
[14] X. Fang,et al. O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer. , 2019, Experimental cell research.
[15] Yan Wang,et al. Integrin-α5 promoted the progression of oral squamous cell carcinoma and modulated PI3K/AKT signaling pathway. , 2019, Archives of oral biology.
[16] K. Alitalo,et al. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis , 2018, Nature Communications.
[17] Wenqi Wang,et al. LncRNA CamK-A Regulates Ca2+-Signaling-Mediated Tumor Microenvironment Remodeling. , 2018, Molecular cell.
[18] Jincai Luo,et al. Heterogeneity of tumor lymphangiogenesis: Progress and prospects , 2018, Cancer science.
[19] Q. Zhan,et al. The chromosome 11q13.3 amplification associated lymph node metastasis is driven by miR-548k through modulating tumor microenvironment , 2018, Molecular Cancer.
[20] M. Detmar,et al. Multiple roles of lymphatic vessels in tumor progression. , 2018, Current opinion in immunology.
[21] T. Zhou,et al. Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion , 2018, Gastric Cancer.
[22] T. Simoncini,et al. Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[23] M. Detmar,et al. Tumor lymphangiogenesis and new drug development. , 2016, Advanced drug delivery reviews.
[24] Baoquan Liu,et al. Integrin α4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF‐C in Human Colon Cancer , 2016, Anatomical record.
[25] N. Gammoh,et al. MicroRNA-26a promotes anoikis in human hepatocellular carcinoma cells by targeting alpha5 integrin , 2014, Oncotarget.
[26] Shu Wu,et al. TBL1XR1 promotes lymphangiogenesis and lymphatic metastasis in esophageal squamous cell carcinoma , 2014, Gut.
[27] Mina J. Bissell,et al. The perivascular niche regulates breast tumor dormancy , 2013, Nature Cell Biology.
[28] J. Alexander,et al. Integrins and Their Extracellular Matrix Ligands in Lymphangiogenesis and Lymph Node Metastasis , 2012, International journal of cell biology.
[29] Q. Paulson,et al. Alcohol promotes breast cancer cell invasion by regulating the Nm23-ITGA5 pathway , 2011, Journal of experimental & clinical cancer research : CR.
[30] S. Hirakawa. From tumor lymphangiogenesis to lymphvascular niche , 2009, Cancer science.
[31] D. McDonald,et al. alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation. , 2009, The American journal of pathology.
[32] B. Garmy-Susini,et al. Integrins in angiogenesis and lymphangiogenesis , 2008, Nature Reviews Cancer.
[33] Zhuang Wu,et al. Tumor lymphangiogenesis and lymphangiogenic growth factors. , 2008, Archives of medical research.
[34] F. Kruse,et al. Inhibition of Inflammatory Lymphangiogenesis by Integrin α5 Blockade , 2007 .
[35] Chang H. Kim. The greater chemotactic network for lymphocyte trafficking: chemokines and beyond , 2005, Current opinion in hematology.
[36] J. Groopman,et al. Extracellular matrix regulates endothelial functions through interaction of VEGFR‐3 and integrin α5β1 , 2005 .
[37] Alexander Marks,et al. Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.
[38] A. Jemal,et al. Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.
[39] Jinghe Huang,et al. articleVascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA / ROCK-2 / moesin cascade , 2010 .